Abstract
Rheumatoid arthritis may take an unfavourable course leading to rapid functional decline in a certain percentage of patients. Early identification of these patients is desirable. The aim of this study was to evaluate clinical and laboratory parameters for their value in the prediction of bad outcome. A total of 172 patients with early arthritis were followed for 3 years. Higher initial values for erythrocyte sedimentation rate, IgG and IgM rheumatoid factor, serum concentration of cartilage oligomeric matrix protein, Health Assessment Questionnaire score, Larsen score of feet, disease activity score, and swollen and tender joint count predicted worse outcome. An association with the presence of IgA rheumatoid factor or anti-cyclic-citrullinated peptide could not be established. We conclude that prognosis in an individual with rheumatoid arthritis depends on many factors. The determination of independent prognostic factors for progression of rheumatoid arthritis is a valuable tool in early arthritis to select patients for more aggressive therapy.
Similar content being viewed by others
Abbreviations
- a-CCP:
-
Anti-cyclic-citrullinated peptide
- ACR:
-
American College of Rheumatology
- AKA:
-
Anti-keratin autoantibodies
- ANOVA:
-
Analysis of variance
- APF:
-
Anti-perinuclear factor
- COMP:
-
Cartilage oligomeric matrix protein
- CRP:
-
C-reactive protein
- DAS:
-
Disease activity score
- DMARD:
-
Disease-modifying anti-rheumatic drug
- EORA:
-
Early onset rheumatoid arthritis
- ESR:
-
Erythrocyte sedimentation rate
- GC:
-
Glucocorticoid
- HAQ:
-
Health assessment questionnaire
- HLA-DRB1:
-
Human leucocyte antigen
- IgA RF:
-
Rheumatoid factor of the immunoglobulin A
- IgG RF:
-
Rheumatoid factor of the immunoglobulin G
- IgM RF:
-
Rheumatoid factor of the immunoglobulin M
- IL-1:
-
Interleukin-1
- LOCF:
-
Last observation carried forward
- LORA:
-
Late-onset rheumatoid arthritis
- MTX:
-
Methotrexate
- MS:
-
Microsoft
- NSAID:
-
Non-steroidal anti-inflammatory drug
- RA:
-
Rheumatoid arthritis
- RF:
-
Rheumatoid factor
- TNF-α:
-
Tumour necrosis factor–alpha
References
Emery P (1994) The optimal management of early rheumatoid disease: the key to preventing disability. Br J Rheumatol 33:765–768
Scott DL, Symmons D, Coulton BL, Popert AJ (1987) Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1:1108–1111
Bellamy N (1991) Prognosis in rheumatoid arthritis. J Rheumatol 18:9
Albers JMC, Paimela L, Kurki P, Eberhardt KB, Emery P, van’t Hof MA, Schreuder FHJM, Leirisalo-REpo M, van Riel PLCM (2001) Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 60:453–458
Corbett M, Dalton S, Young A, Silman A, Shipley M (1993) Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Br J Rheumatol 32:717–723
Jäntti JK, Kaarela K, Belt EA, Kautiainen HJ (2002) Incidence of severe outcome in rheumatoid arthritis during 20 years. J Rheumatol 29:688–692
Lindquist E, Saxne T, Geborek P, Eberhardt K (2002) Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis 61:1055–1059
Suarez-Almazor ME, Soskolne CL, Sounders LD, Russell AS (1994) Outcome in rheumatoid arthritis: a 1985 inception cohort study. J Rheumatol 21:1438–1446
Van der Heijde DMFM, van Riel P, van Leeuwen MA, van’t Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis, a prospective follow-up study of 147 patients. Br J Rheumatol 31(4):519–525
Van Zeben D, Hazes J, Zwinderman AH, Breedveld FC (1993) Factors predicting outcome in rheumatoid arthritis: results of a follow up study. J Rheumatol 20:1288–1296
Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, Meyer O, Sany J, Daurès JP, Dubois A (2001) Prognostic factors for radiographic damage in early rheumatoid arthritis. Arthritis Rheum 44(8):1736–1743
Hein G, Eidner G, Eidner T, Marzoll I, Klinner M (1993) Rheumafaktoraktivität, Manifestationsalter und röntgenologische Progredienz der rheumatoiden Arthritis—eine retrospektive Studie. Z Rheumatol 52:403–408
Van der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ (1995) Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 38(18):1466–1474
Combe B, Cantagrel A, Goupille P, Bozonnat MC, Sibilia J, Eliaou JF, Meyer O, Sany J, Dubois A, Daurès JP et al (2003) Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol 30:2344–2349
Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF (1986) The developement of disability in rheumatoid arthritis. Arthritis Rheum 29(4):494–500
Wolfe F, Hawley DJ, Cathey MA (1991) Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis. J Rheumatol 18:1290–1297
Wolfe F, Cathey MA (1991) The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 18:1298–1306
Sokka T, Häkkinen A, Krishnan E, Hannonen P (2004) Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis 63:494–497
Peltomaa R, Paimela L, Kautiainen H, Leirisalo-Repo M (2002) Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis 61:889–894
Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ, Cerhan JR (2002) Mortality risk associated eith rheumatoid arthritis in a prospective cohort study of older women: results from the Iowa women’s health study. Ann Rheum Dis 61:994–999
Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37(4):481–494
Leigh JP, Fries J (1991) Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol 18:1307–1312
Möttönen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P (1998) Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with “sawtooth” strategy. Ann Rheum Dis 57:533–539
Woolf AD, Hall ND, Goulding NJ, Kantharia B, Maymo J, Evison G, Madison PJ (1991) Predictors of the long-term outcome of early synovitis: a 5-year follow-up study. Br J Rheumatol 30:251–254
Van der Heijde DMFM, van Riel P, van Leeuwen MA, van’t Hof MA, van Rijswijk MH, van de Putte LBA (1991) Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective follow-up study of early rheumatoid arthritis. J Rheumatol 18:1285–1289
Van Schaardenburg D, Hazes JMW, de Boer A, Zwinderman AH, Meijers KAE, Breedveld FC (1993) Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 20:45–52
Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, Cohen AS (1985) The clinical features of elderly-onset rheumatoid arthritis. Arthritis Rheum 28:987–994
Vossenaar ER, van Venrooij WW (2004) Citrullinated proteins: spark that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 6(3):107–11
Skoumal M, Kolarz G, Klingler K (2003) Serum levels of cartilage oligomeric protein (COMP): a prognostic factor and a valuable parameter for disease management in RA. Scand J Rheumatol 32:156–61
Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, van VEnrooij WJ, Klareskog L, Dahlqvist SR (2004) A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigen is strongly associated with future onset of RA. Arthritis Res Ther 6(4):R303–8
Arnett FC, E.S., Bloch DA; McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Plant MJ, Williams AL, O’Sullivan MM, Lewis PA, Coles EC, Jessop JD (2000) Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 43(7):1473–1477
Pepys MB (1993) Rheumatoid arthritis: the role of acute-phase proteins. Br J Rheumatol 32(suppl 3):1–2
Prevoo ML, van`t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Developement and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–8
Van der Heijde DM, van`t Hof MA, van Riel PL, van de Putte LB (1993) Developement of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 20(3):579–81
Buchbinder R, Bombardier C, Yeung M, Tugwell P (1995) Which outcome measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 38(11):1568–1580
Emery P, Luqmani R (1993) The validity of surrogate markers in rheumatic disease. Br J Rheumatol 32(suppl3):3–8
Silman A, Symmons D (1999) Reporting requirements for longitudinal observational studies in rheumatology. Journal Rheumatol 26(2):481–483
Wolfe F, Lassere M, van der Heijde D, Stucki G, Suarez-Almazor M, Pincus T, Eberhardt K, Kvien T, Symmons D, Silman A, van Riel P (1999) Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 26(2):484–9
Larsen A, DK, Elk M (1994) Radiologic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diag 18:481–491
O’Sullivan MM, Lewis PA, Newcombe RG, Broderick NJ, Robinson DA,Coles EC, Jessop JD (1990) Precision of Larsen grading of radiographs in assessing progression of rheumatoid arthritis in individual patients. Ann Rheum Dis 49(3):286–289
The Stepdisc Procedure (1989) In: SAS/STAT User`s guide, Version 6, 4th edn. SAS Institute Inc, Cary, pp 1493–1510
Wolfe F (2001) Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2491 rheumatoid arthritis patients following leflunomide initiation. J Rheumatol 28:982–989
Wolfe F (2000) A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 43(12):2751–2761
Greenwood MC, Doyle DV, Ensor M (2001) Does the Stanford health assessment questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis. Ann Rheum Dis 60:344–348
Aletaha D, Nell V, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7(4):R796–806
Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiologic progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxford) 42(8):939–946
Robbins DL, Leek JC (1986) Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis. J Rheumatol 13:259–262
Bizzaro N (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47(6):1089–93
Kroot EJ (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43(8):1831–5
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagner, E., Ammer, K., Kolarz, G. et al. Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years. Rheumatol Int 27, 1041–1048 (2007). https://doi.org/10.1007/s00296-007-0343-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0343-4